Literature DB >> 7856674

Antepartum surveillance for a history of stillbirth: when to begin?

J W Weeks1, T Asrat, M A Morgan, M Nageotte, S J Thomas, R K Freeman.   

Abstract

OBJECTIVE: A history of stillbirth is universally accepted as an indication for antepartum fetal heart rate testing. Our goal was to examine when fetal testing should begin in an otherwise healthy patient with a history of stillbirth. STUDY
DESIGN: This is a nonconcurrent cohort study of patients who were seen for antepartum surveillance from January 1979 to December 1991 with a history of stillbirth as the only indication for testing. Subsequent pregnancies were evaluated for adverse outcomes and abnormal antepartum test results.
RESULTS: There was one case of recurrent stillbirth among the 300 study patients. Nineteen patients (6.4%) had one or more positive antepartum surveillance tests (positive contraction stress test or biophysical profile < or = 4). Three patients (1%) had positive tests before 32 weeks, all of whom were subsequently delivered without incident at term. Three patients were delivered for positive tests at < 36 weeks, one by cesarean section for fetal distress. We could not detect a relationship between the gestational age of the previous stillborn and the incidence of abnormal tests or fetal distress in subsequent pregnancies.
CONCLUSION: Antepartum surveillance should begin at > or = 32 weeks in the healthy pregnant woman with a history of stillbirth.

Entities:  

Mesh:

Year:  1995        PMID: 7856674     DOI: 10.1016/0002-9378(95)90561-8

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Determinants of perinatal mortality in Marondera district, Mashonaland East Province of Zimbabwe, 2009: a case control study.

Authors:  Emmanuel Tachiweyika; Notion Gombe; Gerald Shambira; Addmore Chadambuka; Tshimamga Mufuta; Simukai Zizhou
Journal:  Pan Afr Med J       Date:  2011-02-02

2.  Antenatal testing-a reevaluation: executive summary of a Eunice Kennedy Shriver National Institute of Child Health and Human Development workshop.

Authors:  Caroline Signore; Roger K Freeman; Catherine Y Spong
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.